Medicine and Dentistry
Breast Cancer
100%
Letrozole
100%
Estrogen Receptor
75%
Hormone Therapy
75%
Combination Therapy
50%
Mammalian Target of Rapamycin Inhibitor
50%
Cells
50%
Induced Resistance
50%
Signal Transduction
25%
In Vitro
25%
Cell Cycle
25%
Hormone
25%
Phosphotransferase
25%
Growth Factor
25%
Kinase Signaling
25%
Fulvestrant
25%
Antiestrogen
25%
Development
25%
Protein Kinase B
25%
Therapy Resistance
25%
Cancer Therapy
25%
mTOR Signaling
25%
Mammalian Target of Rapamycin
25%
Phosphatidylinositol
25%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Letrozole
100%
Mammalian Target of Rapamycin Inhibitor
50%
Phosphotransferase
25%
Hormone
25%
Protein Kinase B
25%
Antiestrogen
25%
Fulvestrant
25%
Phosphatidylinositol
25%
Therapy Resistance
25%